Jwu-Lai Yeh Selected Research

vanylidilol

3/2004

Anti-hypertension effect of vanylidilol: a phenylaldehyde alpha/beta-adrenoceptor blocker with endothelium-dependent and K+ channels opening-associated vasorelaxant activities.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jwu-Lai Yeh Research Topics

Disease

8	Pulmonary Hypertension 01/2021 - 03/2004
7	Vascular Remodeling 06/2022 - 06/2006
6	Inflammation (Inflammations) 01/2022 - 08/2012
6	Hypertension (High Blood Pressure) 07/2020 - 03/2004
5	Cardiomegaly (Heart Hypertrophy) 01/2016 - 03/2010
4	Pulmonary Arterial Hypertension 06/2022 - 01/2016
4	Left Ventricular Dysfunction 01/2020 - 01/2011
4	Myocardial Infarction 02/2016 - 08/2006
4	Heart Failure 06/2006 - 03/2004
3	Vascular Calcification 05/2022 - 01/2020
3	Hyperalgesia 11/2021 - 02/2020
3	Neuralgia (Stump Neuralgia) 11/2021 - 02/2020
3	Hypertrophy 01/2016 - 03/2010
3	Burns 08/2015 - 06/2014
3	Tachycardia (Tachyarrhythmias) 12/2014 - 03/2002
3	Right Ventricular Hypertrophy 06/2014 - 06/2010
2	Pain (Aches) 05/2021 - 02/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2020
2	Abdominal Aortic Aneurysm 06/2020 - 01/2020
2	Ischemia 04/2019 - 01/2011
2	Myocardial Ischemia (Ischemic Heart Diseases) 04/2019 - 08/2006
2	Neointima 01/2019 - 01/2009
2	Hyperplasia 01/2019 - 01/2014
2	Hyperlipidemias (Hyperlipidemia) 09/2018 - 08/2011
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 10/2017 - 11/2012
2	Thrombosis (Thrombus) 01/2017 - 11/2016
2	Hypoxia (Hypoxemia) 06/2016 - 04/2012
2	Osteoporosis 09/2015 - 01/2013
2	Atrophy 08/2015 - 01/2015
2	Cardiac Arrhythmias (Arrythmia) 07/2014 - 01/2011
2	Atherosclerosis 08/2011 - 11/2004
2	Infarction (Infarctions) 01/2011 - 08/2006
2	Status Epilepticus (Complex Partial Status Epilepticus) 01/2007 - 06/2005
2	Seizures (Absence Seizure) 01/2007 - 06/2005
2	Congenital Heart Defects (Congenital Heart Defect) 09/2005 - 09/2005
2	Hypotension (Low Blood Pressure) 08/2005 - 03/2005
1	Neoplasms (Cancer) 06/2022
1	Alveolar Bone Loss 01/2022

Drug/Important Bio-Agent (IBA)

16	KMUP 1IBA 01/2022 - 03/2010
9	XanthineIBA 01/2022 - 03/2010
8	Proteins (Proteins, Gene)FDA Link 11/2021 - 04/2012
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2020 - 03/2010
6	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2020 - 04/2012
6	Endothelin-1 (Endothelin 1)IBA 01/2017 - 03/2004
6	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2017 - 03/2004
6	labedipinedilol AIBA 02/2013 - 11/2004
5	Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA 04/2019 - 03/2010
5	rho-Associated KinasesIBA 01/2017 - 06/2010
4	Soluble Guanylyl CyclaseIBA 01/2022 - 06/2010
4	Matrix Metalloproteinases (MMPs)IBA 05/2021 - 01/2011
4	CalciumIBA 04/2019 - 03/2002
4	Adrenergic Receptors (Adrenergic Receptor)IBA 08/2006 - 03/2002
3	baicaleinIBA 05/2022 - 04/2012
3	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2022 - 09/2015
3	LipopolysaccharidesIBA 01/2022 - 02/2013
3	CytokinesIBA 02/2020 - 01/2014
3	MonocrotalineIBA 07/2019 - 06/2014
3	Mitogen-Activated Protein KinasesIBA 04/2019 - 12/2014
3	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2016 - 11/2012
3	CalcineurinIBA 06/2015 - 03/2010
3	Sildenafil Citrate (Viagra)FDA Link 01/2014 - 06/2006
3	1,4-dihydropyridine (dihydropyridine)IBA 02/2013 - 03/2005
2	loganinIBA 11/2021 - 02/2020
2	Sirtuin 1IBA 05/2021 - 01/2017
2	Vasodilator Agents (Vasodilators)IBA 01/2021 - 03/2004
2	AngiotensinsIBA 01/2021 - 01/2020
2	diminazene aceturateIBA 01/2021 - 01/2020
2	Angiotensin-Converting Enzyme 2IBA 01/2021 - 01/2020
2	xanthohumolIBA 10/2020 - 01/2017
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 07/2020 - 12/2014
2	CollagenIBA 07/2020 - 01/2016
2	Oxidoreductases (Dehydrogenase)IBA 07/2020 - 01/2017
2	Superoxide DismutaseIBA 07/2020 - 01/2019
2	Liraglutide FDA Link 07/2019 - 01/2016
2	Mitogen-Activated Protein Kinase 3IBA 04/2019 - 11/2012
2	GuanosineIBA 04/2019 - 03/2010
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 04/2019 - 03/2010
2	Theophylline (Theon)FDA LinkGeneric 04/2019 - 06/2014
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 09/2018 - 06/2014
2	NADPH Oxidases (NAD(P)H oxidase)IBA 10/2017 - 01/2017
2	Simvastatin (Zocor)FDA LinkGeneric 01/2017 - 06/2016
2	Mitochondrial DNA (mtDNA)IBA 01/2017 - 11/2016
2	Caspase 3 (Caspase-3)IBA 06/2016 - 04/2012
2	NitritesIBA 06/2016 - 04/2012
2	MetalsIBA 08/2015 - 06/2014
2	Atrial Natriuretic Factor (ANF)IBA 06/2015 - 09/2005
2	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 07/2014 - 08/2011
2	salicylhydroxamic acid (SHAM)IBA 06/2014 - 03/2004
2	HMGB1 Protein (HMG1)IBA 01/2014 - 02/2013
2	lercanidipineIBA 02/2013 - 01/2009
2	San-Huang-Xie-Xin-TangIBA 04/2012 - 01/2011
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 03/2010 - 06/2002
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2009 - 08/2006
2	GABA-A Receptors (GABA(A) Receptor)IBA 01/2007 - 06/2005
2	gamma-Aminobutyric Acid (GABA)IBA 01/2007 - 06/2005
1	LigandsIBA 01/2022

Therapy/Procedure

9	Therapeutics 06/2022 - 01/2013
2	Ligation 01/2022 - 01/2017
2	Drug Therapy (Chemotherapy) 06/2020 - 01/2014
2	Denervation 08/2015 - 01/2015